Skip to content

Influence of Intra Canal Medications on Postoperative Flare-up in Endodontic Re-treatment Cases

Influence of Calcium Hydroxide Chlorhexidine Combination vs. Calcium Hydroxide as an Intra Canal Medicaments on Postoperative Flare -up Following Two-Visits Endodontic Retreatment Cases: Single Blinded Randomized Clinical Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03064191
Enrollment
24
Registered
2017-02-24
Start date
2017-09-30
Completion date
2018-04-13
Last updated
2017-09-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Dental, Postoperative Pain

Keywords

intra-canal medications

Brief summary

Is to evaluate the influence of the calcium hydroxide / chlorhexidine combination and calcium hydroxide alone as an intra-canal medication in postoperative flare-up in two visits endodontic retreatment cases

Detailed description

Problem: patient needs retreatment Intervention: calcium hydroxide chlorhexidine combination as an intra-canal medicament Control: calcium hydroxide alone as an intra-canal medicament Outcome: postoperative flare-up (pain and swelling) Time: after 7 days from 1st visit. population will be examined: 1. Patients' needs retreatment. 2. Patients in good health with no systemic disease (American Society of Anesthesiologists Class II) 3. Age range is between 20 and 50 years. 4. Patients who can understand the categorical tool (points)for measurement 5. Patients able to sign informed consent.

Interventions

COMBINATION_PRODUCTcalcium hydroxide chlorhexidine combination

Endodontic intra-canal medicament used for decreasing postoperative signs ans symptoms

OTHERcalcium hydroxide intra-canal medicament

Endodontic intra-canal medicament used for decreasing postoperative signs and symptoms.

Sponsors

Cairo University
CollaboratorOTHER
rayan rabie dahab
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* 1\. Patients' needs retreatment. * 2\. Patients in good health with no systemic disease (American Society of Anesthesiologists Class II) * 3\. Age range is between 20 and 50 years. * 4\. Patients who can understand the categorical tool (points)for measurement * 5\. Patients able to sign informed consent.

Exclusion criteria

* 1\) Complicating systemic disease * 2\) Having severe pain and/or acute apical abscesses * 3\) Being under 18 years of age * 4\) Using antibiotics or corticosteroids, * 5\) having multiple teeth that required retreatment to eliminate the possibility of pain referral * 6\) Having root canals that could not be treated well with initial root canal treatment.

Design outcomes

Primary

MeasureTime frameDescription
measuring patients postoperative pain and swelling following endodontic re-treatment sessions using Categorical (4 points) unit using questionnaire.7 days between the 2 visits ( one week)postoperative pain and swelling will be measured by:Categorical (4 points). The incidence of postoperative discomfort was recorded and expressed as numbers and percentages Subjectively into 4 points: 1. no pain 2. Mild pain: recognizable but not discomforting pain that required no analgesics. 3. Moderate pain: discomforting but bearable pain(analgesics if used were effective in relieving pain) 4. Severe pain: difficult to bear (analgesics were effective in relieving pain). Patients with severe postoperative pain and/or occurrence of swelling were classified as flare-ups.3 Objectively : percussion test

Countries

Egypt

Contacts

Primary Contactassociate professor
Geraldine.ahmed@hotmail.com00201226322227
Backup Contactclinical instructor
dr.nehalnabil@yahoo.com00201202277368

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026